Protein profile

PA3005

beta-hexosaminidase

Genome: NC_002516.2

Gene: PA3005 nagZ Structure source: Experimental + AlphaFold UniProt Q9HZK0
Amino acids 332
Annotations 12
Features 12
PDB binders 10
Druggability 0.825

Overview

Basic information about this protein and its source genome.

Accession
PA3005
Gene
PA3005 nagZ
Status
annotated
Amino acids
332
Structure source
Experimental + AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Gut microbiome off-target
hit
Essential (DEG)
N
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.825
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 11 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

11
  • GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
  • GO:0016231 Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in N-acetyl-beta-D-glucosaminides.
  • GO:0005975 The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
  • GO:0051301 The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
  • GO:0071555 A process that results in the assembly, arrangement of constituent parts, or disassembly of the cell wall, the rigid or semi-rigid envelope lying outside the cell membrane of plant, fungal and most prokaryotic cells, maintaining their shape and protecting them from osmotic lysis.
  • GO:0009252 The chemical reactions and pathways resulting in the formation of peptidoglycans, any of a class of glycoconjugates found in bacterial cell walls and consisting of long glycan strands of alternating residues of beta-(1,4) linked N-acetylglucosamine and N-acetylmuramic acid, cross-linked by short peptides.
  • GO:0009254 The continual breakdown and regeneration of peptidoglycan required to maintain the bacterial cell wall. Peptidoglycans consist of long glycan strands of alternating residues of beta-(1,4) linked N-acetylglucosamine and N-acetylmuramic acid, cross-linked by short peptides.
  • GO:0008360 Any process that modulates the surface configuration of a cell.
  • GO:0046677 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.
  • GO:0004553 Catalysis of the hydrolysis of any O-glycosyl bond.
  • GO:0004563 Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides.

Sequence Features

Domain/signature hits from InterPro and related databases.

12 records
Show feature table
Start End DB Term Name
4 289 PANTHER PTHR30480 BETA-HEXOSAMINIDASE-RELATED
230 247 ProSitePatterns PS00775 Glycosyl hydrolases family 3 active site.
230 247 InterPro IPR019800 Glycoside hydrolase, family 3, active site
1 332 Gene3D G3DSA:3.20.20.300 -
1 332 InterPro IPR036962 Glycoside hydrolase, family 3, N-terminal domain superfamily
12 288 Pfam PF00933 Glycosyl hydrolase family 3 N terminal domain
12 288 InterPro IPR001764 Glycoside hydrolase, family 3, N-terminal
2 332 FunFam G3DSA:3.20.20.300:FF:000001 Beta-hexosaminidase
4 330 Hamap MF_00364 Beta-hexosaminidase [nagZ].
4 330 InterPro IPR022956 Beta-hexosaminidase, bacterial
3 287 SUPERFAMILY SSF51445 (Trans)glycosidases
3 287 InterPro IPR017853 Glycoside hydrolase superfamily

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

7 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
PDB 5G1M
X-ray 1.80 Å A,B
100.0% 1-332
Viewing
PDB 5G6T
X-ray 2.15 Å A,B
100.0% 1-332
Loaded
PDB 5G3R
X-ray 2.18 Å A,B
100.0% 1-332
Loaded
PDB 5G5U
X-ray 2.25 Å A,B
100.0% 1-332
Loaded
PDB 5G2M
X-ray 3.00 Å A,B
100.0% 1-332
Loaded
PDB 5G5K
X-ray 3.10 Å A,B
100.0% 1-332
Loaded
PDB 5LY7
X-ray 3.10 Å A,B
100.0% 1-332
Loaded
AlphaFold PA3005
AlphaFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.825

Pockets (P2RANK)

Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).

P2RANK Sticks Spheres Surfaces Score Probability Labels Zoom Positions
1 16.08 0.769
2 8.86 0.474
3 3.81 0.147
4 2.06 0.046
5 1.98 0.042

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

64 records

Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in TPW, use Open crystal to inspect it in the structure viewer.

Show only:
Ligand Source crystal MW · LogP · TPSA Lipinski PAINS SMILES
NOK 204.2 Da LogP -2.82 TPSA 101.8 ✓ Ro5 ✓ Clean CC(=O)N[C@H]1CN[C@@H]([C@H]([C@@H]1O)O)CO

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.